{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:56:01Z","timestamp":1770724561896,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.medcli.2015.06.015","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T05:32:05Z","timestamp":1441690325000},"page":"392-398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical response to long term enzyme replacement treatment in children, adolescent and adult patients with Hunter syndrome"],"prefix":"10.1016","volume":"145","author":[{"given":"Jaime","family":"Dalmau Serra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidro","family":"Vitoria Mi\u00f1ana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Calder\u00f3n Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isidoro","family":"Cortell Aznar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2015.06.015_bib0005","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.medcli.2015.06.015_bib0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10545-011-9444-z","article-title":"Mucopolysaccharidosis: cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI","volume":"36","author":"Brands","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.medcli.2015.06.015_bib0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejmg.2010.07.013","article-title":"First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS)","volume":"53","author":"Alcalde-Mart\u00edn","year":"2010","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.medcli.2015.06.015_bib0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pediatrneurol.2011.05.010","article-title":"Hunter disease before and during enzyme replacement therapy","volume":"45","author":"Hoffmann","year":"2011","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.medcli.2015.06.015_bib0025","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/ajmg.a.35271","article-title":"Severe phenotype in MPS II patients associated with a large deletion including contiguous genes","volume":"158A","author":"Brusius-Facchin","year":"2012","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.medcli.2015.06.015_bib0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2015.06.015_bib0035","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10545-005-0112-z","article-title":"Cumulative incidence rates of the mucopolysaccharidoses in Germany","volume":"28","author":"Baehner","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.medcli.2015.06.015_bib0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"2008","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.medcli.2015.06.015_bib0045","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s10545-009-1119-7","article-title":"Mortality and cause of death in mucopolysaccharidosis type II \u2013 a historical review based on data from the Hunter Outcome Survey (HOS)","volume":"32","author":"Jones","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.medcli.2015.06.015_bib0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1542\/peds.2007-1350","article-title":"Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome)","volume":"121","author":"Martin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.medcli.2015.06.015_bib0055","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.medcli.2015.06.015_bib0060","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ymgme.2006.09.001","article-title":"A phase I\/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome)","volume":"90","author":"Muenzer","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.medcli.2015.06.015_bib0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/GIM.0b013e3181fea459","article-title":"Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome","volume":"13","author":"Muenzer","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.medcli.2015.06.015_bib0070","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/GIM.0b013e318206786f","article-title":"Idursulfase treatment of Hunter syndrome in children younger than 6 years: results from the Hunter Outcome Survey","volume":"13","author":"Muenzer","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.medcli.2015.06.015_bib0075","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ajmg.a.34415","article-title":"Mucopolysaccharidosis type II in females and response to enzyme replacement therapy","volume":"158A","author":"Jurecka","year":"2012","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.medcli.2015.06.015_bib0080","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.amjcard.2006.02.047","article-title":"Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I","volume":"98","author":"Braunlin","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.medcli.2015.06.015_bib0085","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1017\/S1047951109003576","article-title":"The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses","volume":"19","author":"Fesslov\u00e1","year":"2009","journal-title":"Cardiol Young"},{"key":"10.1016\/j.medcli.2015.06.015_bib0090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1750-1172-6-72","article-title":"Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease","volume":"6","author":"Scarpa","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.medcli.2015.06.015_bib0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ymgme.2011.02.018","article-title":"Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: a perspective from the Hunter Outcome Survey (HOS)","volume":"103","author":"Burton","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.medcli.2015.06.015_bib0100","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.4081\/or.2010.e16","article-title":"Orthopedic manifestations in patients with mucopolysaccharidosis type II (Hunter syndrome) enrolled in the Hunter Outcome Survey","volume":"2","author":"Link","year":"2010","journal-title":"Orthop Rev (Pavia)"},{"key":"10.1016\/j.medcli.2015.06.015_bib0105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/8904_2013_289","article-title":"Enzyme replacement therapy in mucopolysaccharidosis II patients under 1 year of age","volume":"14","author":"Lampe","year":"2014","journal-title":"JIMD Rep"},{"key":"10.1016\/j.medcli.2015.06.015_bib0110","article-title":"The Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale (HS-FOCUS) Questionnaire: evaluation of measurement properties","author":"Wiklund","year":"2012","journal-title":"Qual Life Res"},{"key":"10.1016\/j.medcli.2015.06.015_bib0115","first-page":"S13","article-title":"Follow-up of patients with Hunter syndrome: the Hunter Outcome Survey (HOS) registry","volume":"1","author":"Del Toro-Riera","year":"2007","journal-title":"Rev Neurol"},{"key":"10.1016\/j.medcli.2015.06.015_bib0120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2009.08.006","article-title":"Japan Elaprase\u00ae Treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (mucopolysaccharidosis II, MPS II)","volume":"99","author":"Okuyama","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.medcli.2015.06.015_bib0125","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s10545-007-0613-z","article-title":"Successful treatment of severe heart failure in an infant with Hurler syndrome","volume":"30","author":"Hirth","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.medcli.2015.06.015_bib0130","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1542\/peds.2006-2156","article-title":"Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human \u03b1\u2212l-iduronidase (laronidase)","volume":"120","author":"Wraith","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.medcli.2015.06.015_bib0135","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00431-008-0910-z","article-title":"Mucopolysaccharidosis VI: the Italian experience","volume":"168","author":"Scarpa","year":"2009","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.medcli.2015.06.015_bib0140","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00431-012-1703-y","article-title":"Diagnosing Hunter syndrome in pediatric practice: practical considerations and common pitfalls","volume":"171","author":"Burton","year":"2012","journal-title":"Eur J Pediatr"},{"issue":"Suppl. 5","key":"10.1016\/j.medcli.2015.06.015_bib0145","doi-asserted-by":"crossref","first-page":"v49","DOI":"10.1093\/rheumatology\/ker396","article-title":"Therapy for the mucopolysaccharidoses","author":"Valayannopoulos","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.medcli.2015.06.015_bib0150","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ymgme.2013.08.011","article-title":"Mucopolysaccharidosis type II: identification of 30 novel mutations among Latin American patients","volume":"111","author":"Brusius-Facchin","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.medcli.2015.06.015_bib0155","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3345\/kjp.2012.55.3.88","article-title":"A study of the relationship between clinical phenotypes and plasma iduronate-2-sulfatase enzyme activities in Hunter syndrome patients","volume":"55","author":"Lee","year":"2012","journal-title":"Korean J Pediatr"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775315004005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775315004005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T16:57:03Z","timestamp":1537376223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775315004005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0025775315004005"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2015.06.015","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical response to long term enzyme replacement treatment in children, adolescent and adult patients with Hunter syndrome","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2015.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}